Molecular Diagnostics for Dermatology : Practical Applications of Molecular Testing for the Diagnosis and Management of the Dermatology Patient

The context for the book is the rapid evolution of the field of molecular diagnostics, which is becoming more pervasive in all disciplines of medicine, including dermatology. This is indeed an exciting time in dermatology. Molecular testing is now incorporated into all aspects of patient management,...

Full description

Main Authors: Hosler, Gregory A., Murphy, Kathleen M. (Author)
Corporate Author: SpringerLink (Online service)
Format: eBook
Language:English
Published: Berlin, Heidelberg Springer Berlin Heidelberg 2014, 2014
Edition:1st ed. 2014
Subjects:
Online Access:
Collection: Springer eBooks 2005- - Collection details see MPG.ReNa
LEADER 03839nmm a2200361 u 4500
001 EB000738996
003 EBX01000000000000000590428
005 00000000000000.0
007 cr|||||||||||||||||||||
008 140505 ||| eng
020 |a 9783642540660 
100 1 |a Hosler, Gregory A. 
245 0 0 |a Molecular Diagnostics for Dermatology  |h Elektronische Ressource  |b Practical Applications of Molecular Testing for the Diagnosis and Management of the Dermatology Patient  |c by Gregory A. Hosler, Kathleen M. Murphy 
250 |a 1st ed. 2014 
260 |a Berlin, Heidelberg  |b Springer Berlin Heidelberg  |c 2014, 2014 
300 |a XVIII, 356 p. 83 illus., 79 illus. in color  |b online resource 
505 0 |a Introduction -- Terms and Definitions -- Basics of Molecular Biology and Nucleic Acids -- Principles of the Molecular Basis for Disease -- Molecular Testing Methods -- PCR and PCR-based Assays -- In situ Hybridization -- FISH and Cytogenetics -- Comparative Genomic Hybridization -- Microarray Analysis -- Melanoma -- Cutaneous Lymphoma and Leukemia Cutis -- Soft Tissue tumors -- Genodermatoses -- Infectious Disease -- Viral -- Bacterial and Mycobacterial -- Fungi and Parasites -- Emerging Molecular Applications in Dermatology -- Pharmacogenetics/Pharmacogenomics -- Theranostics 
653 |a Pathology 
653 |a Dermatology 
653 |a Laboratory Medicine 
653 |a Pathology 
653 |a Laboratory medicine 
653 |a Dermatology 
700 1 |a Murphy, Kathleen M.  |e [author] 
710 2 |a SpringerLink (Online service) 
041 0 7 |a eng  |2 ISO 639-2 
989 |b Springer  |a Springer eBooks 2005- 
856 |u https://doi.org/10.1007/978-3-642-54066-0?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 616.5 
520 |a The context for the book is the rapid evolution of the field of molecular diagnostics, which is becoming more pervasive in all disciplines of medicine, including dermatology. This is indeed an exciting time in dermatology. Molecular testing is now incorporated into all aspects of patient management, including diagnostics (identifying and classifying disease), prognostics (predicting disease course), and theranostics (predicting response to therapy). For example, molecular tests are now used to detect germline mutations that result in genodermatoses, somatic genetic events that characterize tumors such as melanoma and sarcomas, and genetic material of otherwise undetectable infectious organisms. For melanoma and lymphoma, testing can potentially predict tumor behavior and modify patient staging.  
520 |a This textbook presents the current (and near-future) state of affairs of molecular testing as it pertains to the dermatology patient. It focuses on practical applications of molecular diagnostics over a cross-section of dermatologic disease, including melanoma, lymphoma, soft tissue tumors, genodermatoses, and infectious disease. It includes practical advice to those ordering molecular tests as well as to those considering performing such tests, providing a potential template for a comprehensive dermatologic molecular diagnostics test menu. Pitfalls of interpretation and algorithmic approaches to testing are included. The textbook is directed towards all readers – clinicians, pathologists, laboratorians, and other inquisitive minds – independent of their level of molecular expertise, to provoke thought or perhaps even change practice.  
520 |a Regarding theranostics, molecular tests that identify specific mutations in proto-oncogenes, such as BRAF and others, are now used to predict which patients will respond to designer targeted therapies. Molecular theranostics has revolutionized the entire treatment paradigm for patients with advanced melanoma, replacing “excise and pray” approaches with personalized medicine